NCT06779513 Validation and Assessment of Novel Morphology-Voltage-P-wave Score for Diagnosing Left Ventricular Diastolic Dysfunction in Patients With Hypertension
| NCT ID | NCT06779513 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitas Diponegoro |
| Condition | Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2024-01-01 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aimed to assess and validate the diagnostic utility of a novel Morphology-Voltage-P-wave Score (MVP Score) in identifying left ventricular diastolic dysfunction among patients with hypertension. Researchers will collect information of patient with hypertension and underwent transthoracal echocardiography assessment. The data consist of demographic data, clinical presentation, laboratory, and echocardiography result were collected by two investigators. Then, the data was analyzed by using IBM SPSS Statistics v26.
Eligibility Criteria
Inclusion Criteria: * Essential hypertension Exclusion Criteria: * Secondary or resistant hypertension * LVEF\<55% * Congenital heart disease * Infiltrative cardiomyopathy * Coronary artery disease * Chronic kidney disease * Valvular heart disease * Bundle branch block * Arrhythmia
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06779513 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06779513 currently recruiting?
Yes, NCT06779513 is actively recruiting participants. Contact the research team at dancingdeagle@gmail.com for enrollment information.
Where is the NCT06779513 trial being conducted?
This trial is being conducted at Semarang, Indonesia.
Who is sponsoring the NCT06779513 clinical trial?
NCT06779513 is sponsored by Universitas Diponegoro. The trial plans to enroll 50 participants.